$3.33
-0.07(-1.91%)
Mkt Cap $128M
$1.62
$7.06
52-Week Range
At a Glance
AI-generatedRevenue breakdown: Non Cash Royalty Revenue (47.7%), Non Cash Royalty Revenue Related To The Sale Of Future Royalties (23.8%), Research And Development Revenue (7%).
8-K
On March 24, 2026, the United States District Court for the District of Massachusetts granted Agenus Inc. and individual defendants Garo H. Armen, Christine M. Klaskin, Steven J. O'Day, and Todd Yancey motion to dismiss in its entirety the amended complaint in the putative securities class action Byron Olsen v. Agenus Inc. et al., Civil Action No. 24-CV-12299-AK. The court also denied the plaintiff’s request for leave to amend.$128M
Market Cap
$124M
Revenue
$125.0K
Net Income
Employees316
Fundamentals
How The Business Makes Money
Revenue by Segment
Non Cash Royalty Revenue47.7%($522M)
Non Cash Royalty Revenue Related To The Sale Of Future Royalties23.8%($261M)
Research And Development Revenue7%($77M)
Royalty Sales Milestone6.9%($76M)
License Fee Revenue5.5%($60M)
Recognition Of Deferred Research And Development Revenue4%($44M)
Other2.8%($31M)
Revenue1.4%($15M)
Research And Development Services0.6%($6M)
Clinical Product Revenue0.2%($3M)
Revenue by Geography
US93.6%($685M)
Non Us4.2%($31M)
Rest Of World2.1%($15M)
Activity
What Changed Recently
Analyst View
Company Profile
CIK0001098972
ISINUS00847G8042
CUSIP00847G804
Phone781 674 4400
Address3 Forbes Road, Lexington, MA, 02421-7305, US
SEC EDGAR